Deleting the Ube3a gene alters the social behavior of mice in a way that may mimic that of humans with…
Patricia Inacio, PhD
Patricia holds her PhD in cell biology from the University Nova de Lisboa, Portugal, and has served as an author on several research projects and fellowships, as well as major grant applications for European agencies. She also served as a PhD student research assistant in the Department of Microbiology & Immunology, Columbia University, New York, for which she was awarded a Luso-American Development Foundation (FLAD) fellowship.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Patricia Inacio, PhD
Researchers have developed a method to study the enzymes involved in the disposal of proteins that are faulty or no…
University of California researchers have developed a touchscreen test for mice with Angelman syndrome that they believe will shed additional…
The U.S. Food and Drug Administration (FDA) awarded a fast track designation to Ovid Therapeutics’ OV101 for the treatment…
Ovid Therapeutics presented data from several studies that support the clinical development of the investigational therapy TAK-935/OV935 as a…
Agilis Biotherapeutics, which develops innovative DNA therapeutics for rare diseases of the central nervous system, presented the latest results…
Throughout evolution, genomic recycling of protein-coding genes gave rise to part of non-coding genes within our genome, known as long…
A new, revised protocol of the non-invasive prenatal test (NIPT) Panorama identifies genetic abnormalities underlying Angelman and four other syndromes…